Read More 1 minute read M&A News News Merck Acquires Caraway Therapeutics in a Landmark $610 Million Deal Key Highlights Merck to acquire Caraway Therapeutics, a biopharmaceutical company focusing on neurodegenerative and rare diseases, for a… byChris-Anne RoqueNovember 29, 2023